Anatomical and Functional Outcomes of Macular Edema Complicating Retinal Vein Occlusions (RVO) Treated with Intravitreal Anti-VEGF Injections at Bouaké University Hospital
Journal of Ophthalmology and Advance Research · 15.11.2026 · 7 (3) · 1-7
DOI: 10.46889/joar.2026.7309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ophthalmology and Advance Research, online erschienen am 15.11.2026. Verfasst von Goule AM und 11 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objective
To describe the anatomical and functional outcomes of macular edema complicating Retinal Vein Occlusion (RVO) in patients treated with intravitreal anti-VEGF injections, with the aim of improving its management. Patients and methods: This was a prospective descriptive study conducted in the Department of Ophthalmology of Bouaké University Hospital from 18/08/2023 to 18/08/2025, over a period of 24 months. All patients with an accessible fundus examination, in whom RVO complicated by macular edema was confirmed by OCT and who received three intravitreal anti-VEGF injections (aflibercept), were included. Patients in whom macular edema could not be confirmed by OCT and those who did not receive the three intravitreal anti-VEGF injections were excluded. The parameters studied were epidemiological (age, sex, occupation, risk factors), clinical (distance visual acuity, intraocular pressure, RVO location, fundus lesions before and after anti-VEGF injections) and para -clinical (central foveal thickness before and after anti-VEGF injections). Data entry and analysis were performed using Epi Info version 7.1.3. Word-processing and tables were produced using Microsoft Word.
Results
The hospital frequency of macular edema complicating RVO was 30% (n=24). The mean age was 58.41 years, ranging from 31 to 77 years. There was a male predominance of 75% (n=18), with a sex ratio of 3. The most common risk factor was glaucoma, in 50% (n=12) of cases. The right eye was most affected, accounting for 58.33% of cases (n=14). Initial distance visual acuity was ≤1/20 in 83.33% (n=20) of cases. Mean intraocular pressure was 23.33 mmHg, ranging from 18 to 35 mmHg. Central Retinal Vein Occlusion (CRVO) predominated in 50% of cases (n=12), followed by inferior Branch Retinal Vein Occlusion (BRVO) in 41.66% (n=10). Mean central macular thickness was 524.58 µm, ranging from 292 to 1075 µm. After three anti-VEGF injections, clinical signs of RVO and macular edema regressed in 100% of cases (n=24). Distance visual acuity improved to between 1/10 and 3/10 in 91.66% (n=22) of patients and central macular thickness decreased by 291.33 µm, with a mean post-treatment central macular thickness of 233.25 µm.
Conclusion
Intravitreal aflibercept injections in the management of macular edema complicating retinal vein occlusions improve the anatomical and functional prognosis of the affected eye.
Zitieren
APA
AM, G., GF, D., KF-H, K., KAP, K., MP, K., L, G., Z, D., RLO, B., G, I., PEFK, B., Y, O., & IA, D. (2026). Anatomical and Functional Outcomes of Macular Edema Complicating Retinal Vein Occlusions (RVO) Treated with Intravitreal Anti-VEGF Injections at Bouaké University Hospital. Journal of Ophthalmology and Advance Research, 7(3), 1-7. https://doi.org/10.46889/joar.2026.7309
Vancouver
AM G, GF D, KF-H K, KAP K, MP K, L G, et al. Anatomical and Functional Outcomes of Macular Edema Complicating Retinal Vein Occlusions (RVO) Treated with Intravitreal Anti-VEGF Injections at Bouaké University Hospital. Journal of Ophthalmology and Advance Research. 2026;7(3):1-7. doi:10.46889/joar.2026.7309
BibTeX
@article{AM2026,
author = {AM, Goule and GF, Diomandé and KF-H, Koffi and KAP, Koffi and MP, Konan and L, Godé and Z, Diabaté and RLO, Babayeju and G, Ikpo and PEFK, Bilé and Y, Ouattara and IA, Diomandé},
title = {Anatomical and Functional Outcomes of Macular Edema Complicating Retinal Vein Occlusions (RVO) Treated with Intravitreal Anti-VEGF Injections at Bouaké University Hospital},
journal = {Journal of Ophthalmology and Advance Research},
year = {2026},
volume = {7},
number = {3},
pages = {1--7},
doi = {10.46889/joar.2026.7309}
}
EUVIMED